Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. Its Sanara Surgical segment primarily markets and sells soft tissue repair and bone fusion products for use in the operating room or other sterile environments. Its Tissue Health Plus segment is focused on value-based wound care services. It markets and distributes CellerateRX Surgical Activated Collagen, FORTIFY TRG Tissue Repair Graft and FORTIFY FLOWABLE Extracellular Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN Verified Inductive Bone Matrix, ALLOCYTE Plus Advanced Viable Bone Matrix, BiFORM Bioactive Moldable Matrix, TEXAGEN Amniotic Membrane Allograft, and BIASURGE Advanced Surgical Solution to the surgical market. BIAKOS Antimicrobial Wound Gel and others are the products sold in the wound care market.
äŒæ¥ã³ãŒãSMTI
äŒç€ŸåSanara Medtech Inc
äžå Žæ¥Apr 07, 1994
æé«çµå¶è²¬ä»»è
ãCEOãMuppalla (Suresh V)
åŸæ¥å¡æ°141
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Apr 07
æ¬ç€Ÿæåšå°1200 Summit Avenue
éœåžFORT WORTH
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœUnited States of America
éµäŸ¿çªå·76102
é»è©±çªå·18175292300
ãŠã§ããµã€ãhttps://sanaramedtech.com/
äŒæ¥ã³ãŒãSMTI
äžå Žæ¥Apr 07, 1994
æé«çµå¶è²¬ä»»è
ãCEOãMuppalla (Suresh V)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã